Literature DB >> 26546220

Attenuation of TNF-α secretion by L-proline-based cyclic dipeptides produced by culture broth of Pseudomonas aeruginosa.

Rukaiyya Khan1, Ameer Basha2, Ragavendra Goverdhanam2, Poorna Chandra Rao1, Yuhei Tanemura3, Yoshinori Fujimoto3, Ahil Sajeli Begum4.   

Abstract

To identify small molecule inhibitors of TNF-α, bioassay- and LC-MS-guided chemical investigation on EtOAc extract of Pseudomonas aeruginosa ABS-36 culture broth (EEPA) was performed, which yielded four proline-based cyclic dipeptides, cyclo(Gly-l-Pro) (1), cyclo(l-Pro-l-Phe) (2), cyclo(trans-4-hydroxy-l-Pro-l-Phe) (3) and cyclo(trans-4-hydroxy-l-Pro-l-Leu) (4). Compounds 1 and 3 exhibited potent inhibition of TNF-α release with IC50 values of 4.5 and 14.2μg/mL, respectively, while EEPA showed IC50 of 38.8μg/mL under lipopolysaccharide treated RAW 264.7 cell ELISA assay. Also, marked attenuation of mRNA-expression of TNF-α was shown by all compounds. In vivo testing in rats of EEPA and chemically synthesized 4 validated significant TNF-α reduction with 51% (500mg/kg) and 79% (50mg/kg), respectively. In addition, all compounds exhibited significant diminution of IL-1β and IL-6 mRNA-expression levels and NO production. All samples displayed only weak toxicity to lipopolysaccharide-induced RAW 264.7 cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclic dipeptide; Interleukin-1β; Interleukin-6; Pseudomonas aeruginosa; TNF-α inhibitor

Mesh:

Substances:

Year:  2015        PMID: 26546220     DOI: 10.1016/j.bmcl.2015.10.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Anti-Inflammatory Effects of an Extract from Pseudomonas aeruginosa and Its Purified Product 1-Hydroxyphenazine on RAW264.7 Cells.

Authors:  Jun Xiao; Aye Aye Thwe; Tingting Liu; Dafei Gong; Wanhua Lin; Changhua Shang; ZuJun Lu
Journal:  Curr Microbiol       Date:  2021-05-27       Impact factor: 2.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.